603717 天域生物
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-14.476-22.961-18.440-52.666-24.726
总资产报酬率 ROA (%)-1.892-3.500-3.310-13.779-9.241
投入资产回报率 ROIC (%)-3.124-5.550-4.988-20.336-13.355

边际利润分析
销售毛利率 (%)-0.966-0.12510.833-34.41811.326
营业利润率 (%)-14.571-14.045-11.188-84.931-34.186
息税前利润/营业总收入 (%)-13.067-12.013-9.631-83.382-31.980
净利润/营业总收入 (%)-14.718-14.060-10.835-84.404-28.415

收益指标分析
经营活动净收益/利润总额(%)96.906114.58353.41262.3899.504
价值变动净收益/利润总额(%)-22.849-4.6960.2456.237-0.582
营业外收支净额/利润总额(%)-4.177-5.899-2.8831.583-1.968

偿债能力分析
流动比率 (X)0.8990.8501.0791.3141.693
速动比率 (X)0.7230.6800.9131.1861.481
资产负债率 (%)80.98779.48177.96274.50559.130
带息债务/全部投入资本 (%)61.22360.34255.96850.30942.066
股东权益/带息债务 (%)31.96539.04944.09758.272112.619
股东权益/负债合计 (%)14.65117.93520.69626.48054.637
利息保障倍数 (X)-14.214-9.616-7.744-28.604-20.685

营运能力分析
应收账款周转天数 (天)178.892171.278173.209229.198198.575
存货周转天数 (天)115.006111.11796.56279.76774.263